Previous close | 4.0500 |
Open | 4.0600 |
Bid | 4.0000 x 200 |
Ask | 4.0300 x 200 |
Day's range | 4.0000 - 4.0600 |
52-week range | 3.9500 - 16.1800 |
Volume | |
Avg. volume | 391,926 |
Market cap | 85.018M |
Beta (5Y monthly) | 0.70 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.20 (13.07%) |
Ex-dividend date | 11 Aug 2023 |
1y target est | N/A |
Fiscal 2024 3Q Revenue of $65.3 million, an 11% increase compared to last year including PetCareRx results.AutoShip & Save and PetPlus Membership, 52% of total revenue, up from 42% at the same time last year.Strong balance sheet with $49.4 million of cashThe Company is now current in all of its SEC filings DELRAY BEACH, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS)(“PetMeds” or “Company”), Your Trusted Pet Health ExpertTM, today announced its financial results for
The giveaway comes as PetMeds® partners with Hill’s Pet Nutrition to make Science Diet available through petmeds.com, starting March 1DELRAY BEACH, Fla., Feb. 16, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS), Your Trusted Pet Health Expert, is giving away a year’s worth of free science-led Hill’s Science Diet pet nutrition to three lucky winners. Those three winners will also get to select a pet shelter of their choice to receive a $1,000 credit to petmeds.com. The giveaway will
DELRAY BEACH, Fla., Feb. 15, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (“PetMeds®”) (NASDAQ: PETS), received on February 13, 2024, a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of not having timely filed the Form 10-Q with the SEC, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires timely filing of all required periodic financial reports with the SEC. The Notice has no immediate effect o